Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXAS1 | P24557 | 9/20 | 0.57 |
| ▸ | FDPS | P14324 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | QPCT | Q16769 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Diethyl Hydrogen Phosphate SCHEMBL4952771 | 0.91 | FDPS (0.49) | TBXAS1FDPSLMNAKDM4EQPCT | |
| SCHEMBL28344906 | 0.90 | TBXAS1 (0.55) | TBXAS1FDPSLMNAKDM4EQPCT | |
| Phosphoric Acid SCHEMBL28028750 | 0.88 | TBXAS1 (0.68) | TBXAS1FDPSLMNAQPCTSMN1; SMN2 | |
| SCHEMBL31154488 | 0.87 | TBXAS1 (0.58) | TBXAS1FDPSLMNAKDM4EQPCT | |
| SCHEMBL5289567 | 0.84 | TBXAS1 (0.64) | TBXAS1FDPSQPCTSMN1; SMN2MAPK1 | |
| Diethyl Hydrogen Phosphate SCHEMBL4951600 | 0.84 | FDPS (0.47) | TBXAS1FDPSLMNAKDM4E | |
| Phosphoramidic Acid SCHEMBL2236407 | 0.84 | TBXAS1 (0.64) | TBXAS1FDPSLMNAQPCTSMN1; SMN2 | |
| SCHEMBL28141331 | 0.83 | TBXAS1 (0.63) | TBXAS1FDPSLMNAKDM4ESMN1; SMN2 | |
| Phosphoric Acid SCHEMBL29074288 | 0.83 | TBXAS1 (0.77) | TBXAS1FDPSQPCTSMN1; SMN2MAPK1 | |
| SCHEMBL29647972 | 0.82 | TBXAS1 (0.47) | TBXAS1FDPSLMNAQPCTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008022983-A2 | CONDUCTIVE POLYMER GELS | BASF SE (DE) | 2008-02-28 | — | — | WO | claimed |
| EP-1663921-B1 | METHOD FOR PRODUCING HALOALKANES FROM ALCOHOLS | BASF AG (DE) | 2007-05-02 | — | — | EP | claimed |
| US-20070055084-A1 | Method for producing haloalkanes from alcohols | BASF AKTIENGESELLSCHAFT (DE) | 2007-03-08 | — | — | US | claimed |
| WO-2018069237-A1 | BETAINE (B) AND METHOD FOR THE PRODUCTION THEREOF | BASF SE (DE) | 2018-04-19 | — | — | WO | disclosed |
| WO-2008022983-A2 | CONDUCTIVE POLYMER GELS | BASF SE (DE) | 2008-02-28 | — | — | WO | disclosed |
| EP-1663921-B1 | METHOD FOR PRODUCING HALOALKANES FROM ALCOHOLS | BASF AG (DE) | 2007-05-02 | — | — | EP | disclosed |
| US-20070055084-A1 | Method for producing haloalkanes from alcohols | BASF AKTIENGESELLSCHAFT (DE) | 2007-03-08 | — | — | US | disclosed |
| EP-1663921-A2 | METHOD FOR PRODUCING HALOALKANES FROM ALCOHOLS | BASF AKTIENGESELLSCHAFT (DE) | 2006-06-07 | — | — | EP | disclosed |
| WO-2005026089-A2 | METHOD FOR PRODUCING HALOALKANES FROM ALCOHOLS | BASF AKTIENGESELLSCHAFT (DE) | 2005-03-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070055084-A1 | Method for producing haloalkanes from alcohols | ADH1C, HDHD5, ADH5 | TBXAS1 2565/4885FDPS 2441/4885LMNA 1728/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.